Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Adam Levin, MD, Ariel Kleman, MD, Lisa Rein, MS, Sergey Tarima, PhD, Laura C Michaelis, MD, Karen-Sue B. Carlson, MD PhD, Mehdi Hamadani, MD, Timothy S. Fenske, MD, Parameswaran Hari, MBBS, MD MRCP, Ehab Atallah, MD, Binod Dhakal, MD MS

Blood (2016) 128 (22): 2784.

https://doi.org/10.1182/blood.V128.22.2784.2784

Published: 2016

Journal Articles

Use of "Big Data" to Define Disease Burden, Complication Rates and Healthcare Costs in Patients with Heparin Induced Thrombocytopenia (HIT)

Binod Dhakal, MDMS, Parameswaran Hari, MBBS, MD MRCP, Lisa Rein, MS, Raphael Fraser, PhD, Anand Padmanabhan, MBBS, MA, PhD

Blood (2016) 128 (22): 418.

https://doi.org/10.1182/blood.V128.22.418.418

Published: 2016

Journal Articles

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Shaji Kumar, MD, Meletios A Dimopoulos, Efstathios Kastritis, MD, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Xavier Leleu, Meral Beksac, MD, Melissa Alsina, MD, Albert Oriol, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Maria Victoria Mateos, Elizabeth K. O'Donnell, MD, Ravi Vij, MD MBA, Henk M. Lokhorst, MD PhD, Niels W.C.J. van de Donk, MD PhD, Chang-Ki Min, Tomer Mark, MD MSc, Ingemar Turesson, MD, PhD, Markus Hansson, MD, Heinz Ludwig, Sundar Jagannath, MD, Michel Delforge, MD PhD, Charalampia Kyriakou, MD PhD, Parameswaran Hari, MBBS, MD MRCP, Ulf-Henrik Mellqvist, MD PhD, Saad Z Usmani, MD FACP, Dominik Dytfeld, MD PhD, Ashraf Z Badros, MD, Philippe Moreau, Kihyun Kim, MD PhD, Paula Rodriguez Otero, MD, Jae Hoon Lee, MD, Chaim Shustik, MD, Daniel Waller, PhD, Wee Joo Chng, MD PhD, Shuji Ozaki, MD PhD, Je-Jung Lee, Javier de la Rubia, Hyeon Seok Eom, MD PhD, Laura Rosinol, MD PhD, Juan José Lahuerta, MD PhD, Anna Sureda, MD PhD, Jin Seok Kim, MD PhD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 4414.

https://doi.org/10.1182/blood.V128.22.4414.4414

Published: 2016

Journal Articles

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

Ensi Voshtina, DO, Aniko Szabo, PhD, Mehdi Hamadani, MD, Tim S. Fenske, MD, Anita D'Souza, MBBS, MD, Wael Saber, MD MS, William R. Drobyski, MD, Parameswaran Hari, MBBS, MD MRCP, Nirav N. Shah, MD MSHP

Blood (2016) 128 (22): 4667.

https://doi.org/10.1182/blood.V128.22.4667.4667

Published: 2016

Journal Articles

"Tailoring" Hematopoietic Progenitor Cell Collection: Impact of a Data-Driven Prediction Algorithm for Blood Volume Processing in Large Volume Leukapheresis

Binod Dhakal, MD MS, Lori Eggert, Gautham Benoy, Patricia Fredrich, Sorelle Jefcik, Parameswaran Hari, MBBS, MD MRCP, David A Margolis, MD, Carolyn A. Keever-Taylor, PhD, Rowena Punzalan, MD, Anand Padmanabhan, MBBS, MA, PhD

Blood (2016) 128 (22): 2188.

https://doi.org/10.1182/blood.V128.22.2188.2188

Published: 2016

Journal Articles

Phase 2 Study of Carfilzomib (CFZ) with or without Filanesib (FIL) in Patients with Advanced Multiple Myeloma (MM)

Blood (2015) 126 (23): 728.

https://doi.org/10.1182/blood.V126.23.728.728

Published: 2015

Journal Articles

A Novel Tool Using Marrow Natural Killer (NK) Cell Percentages to Predict Collection Requirements of Peripheral Blood Mononuclear Cell (MNC), Apheresis Products Used in NK Cell Adoptive Immunotherapy

Carolyn A. Keever-Taylor, PhD, Anand Padmanabhan, MBBS, MA, PhD, Parameswaran Hari, MBBS, MD MRCP, Monica S Thakar, MD

Blood (2014) 124 (21): 3851.

https://doi.org/10.1182/blood.V124.21.3851.3851

Published: 2014

Journal Articles

Phase 1B Results of Ricolinostat (ACY-1215) Combination Therapy with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma (MM)

Dan T. Vogl, Noopur Raje, MD, Parameswaran Hari, MBBS, MD MRCP, Simon S Jones, PhD, Jeffrey G Supko, PhD, Gina Leone, RN, Catherine Wheeler, MD, Robert Z. Orlowski, PhD MD, Paul G. Richardson, Sagar Lonial, MD, David Tamang, PhD, Sundar Jagannath, MD

Blood (2014) 124 (21): 4764.

https://doi.org/10.1182/blood.V124.21.4764.4764

Published: 2014

Journal Articles

D-Dimer Kinetics, Chemotherapy and Risk of Bleeding in Acute Promyelocytic Leukemia

Namrata Peswani, MD MBBS, Baumann Lisa, MD, Karen Carlson, MD PhD, Laura C Michaelis, MD, Christopher R. Chitambar, MD, Timothy S. Fenske, MD, Parameswaran Hari, MBBS, MD MRCP, Ehab Atallah, MD

Blood (2014) 124 (21): 1490.

https://doi.org/10.1182/blood.V124.21.1490.1490

Published: 2014

Journal Articles

A Phase 1/2 Study of Weekly MLN9708, an Investigational Oral Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)

Shaji K. Kumar, MD, Jesus G. Berdeja, MD, Ruben Niesvizky, MD, Sagar Lonial, MD, Mehdi Hamadani, MD, A. Keith Stewart, MBA, MB, CHB, Vivek Roy, M.D., Parameswaran Hari, MBBS, MD, MRCP, Robert Vescio, MD, Deborah Berg, RN, MSN, Jianchang Lin, Alessandra Di Bacco, PhD, Neeraj Gupta, PhD, Ai-Min Hui, MD, Paul G. Richardson, MD

Blood (2012) 120 (21): 332.

https://doi.org/10.1182/blood.V120.21.332.332

Published: 2012

Journal Articles

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

Merav Bar, MD, Barry Storer, PhD, Benedetto Bruno, MD, Parameswaran Hari, MBBS, MD, MRCP, Thomas Chauncey, MD, PhD, Yoshihiro Inamoto, MD, PhD, Paul J. Martin, MD, Rainer Storb, MD, David G. Maloney, MD, PhD, Brenda M. Sandmaier, MD, Mary E.D. Flowers, MD

Blood (2012) 120 (21): 354.

https://doi.org/10.1182/blood.V120.21.354.354

Published: 2012

Journal Articles

Intermittent Zolendronic Acid (ZA) for the Prevention of Osteoporosis After Allogeneic Hematopoietic Cell Transplantation (HCT)

Parameswaran Hari, MBBS, MD, MRCP, Todd E. Defor, MS, David H. Vesole, MD, PhD, Christopher Bredeson, MD, MSc, FRCPC, Linda J Burns, MD

Blood (2012) 120 (21): 1965.

https://doi.org/10.1182/blood.V120.21.1965.1965

Published: 2012

Journal Articles

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Vikas Gupta, MD, FRCP, FRCPath, Kwang W Ahn, PhD, Xiaochun Zhu, MS, Zhenhuan Hu, MPH, Parameswaran Hari, MBBS, MD, MRCP, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Wael Saber, MD, MS

Blood (2012) 120 (21): 432.

https://doi.org/10.1182/blood.V120.21.432.432

Published: 2012

Journal Articles

Hematopoietic Cell Transplant Co-Morbidity Index (HCTCI) and Multiple Myeloma (MM) Survival After Autologous Hematopoietic Cell Transplantation (AHCT)

Anuj Mahindra, Ayman A Saad, MD, Mei-Jie Zhang, PhD, Xiaobo Zhong, MS, Angela Dispenzieri, MD, Amrita Krishnan, MD, Sagar Lonial, MD, Marcelo C Pasquini, MD, MS, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 4217.

https://doi.org/10.1182/blood.V120.21.4217.4217

Published: 2012

Journal Articles

Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Girindra Raval, Anuj Mahindra, MD, Xiaobo Zhong, MS, Ruta Brazauskas, PhD, Robert Peter Gale, MD, PhD, DSc, FACP, Nancy Brandenburg, PhD, Sagar Lonial, MD, Amrita Krishnan, MD, Angela Dispenzieri, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 591.

https://doi.org/10.1182/blood.V120.21.591.591

Published: 2012

Journal Articles

Trends in Utilization and Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in the Upfront Management of Patients with Multiple Myeloma: A Cibmtr Analysis

Luciano J. Costa, MD, PhD, Xiaobo Zhong, MS, Mei-Jie Zhang, PhD, Sagar Lonial, MD, Amrita Krishnan, MD, Angela Dispenzieri, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 596.

https://doi.org/10.1182/blood.V120.21.596.596

Published: 2012

Journal Articles

Pre-Transplant Salvage Therapy Prior to Autologous Transplant (AHCT) in Patients Not Responding to Initial Induction for Multiple Myeloma (MM)

Ravi Vij, MBBS, Xiaobo Zhong, MS, Mei-Jie Zhang, PhD, Sagar Lonial, MD, Angela Dispenzieri, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2012) 120 (21): 597.

https://doi.org/10.1182/blood.V120.21.597.597

Published: 2012

Journal Articles

The Impact of Co-Morbidities on the Outcome of Autologous Stem Cell Transplantation for Multiple Myeloma

Ayman A Saad, MD, Marc Sala, MD, Niravkumar A. Naik, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 4511.

https://doi.org/10.1182/blood.V118.21.4511.4511

Published: 2011

Journal Articles

Biomarker Correlation with Outcomes in Patients with Relapsed or Refractory Multiple Myeloma on a Phase I Study of Everolimus in Combination with Lenalidomide,

Andrew J. Yee, MD, Anuj K. Mahindra, MD, Paul G. Richardson, MD, Diana D. Cirstea, MD, Tyler A. Scullen, BA, Scott J. Rodig, MD, PhD, Teru Hideshima, MD, PhD, Parameswaran Hari, MBBS, MD, MRCP, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Nikhil C. Munshi, MD, Edie A. Weller, PhD, Kenneth C. Anderson, MD, Noopur S. Raje, MD

Blood (2011) 118 (21): 3966.

https://doi.org/10.1182/blood.V118.21.3966.3966

Published: 2011

Journal Articles

Bortezomib Based Therapy for Newly Diagnosed Patients with Advanced Multisystem Light Chain Amyloidosis (AL)

Leena Varkey Maramattom, MD, Mazie Froedtert Willms & Sue Froedtert Cancer Fellow, Veerpal Singh, MD, Robert Frank Cornell, MD, Jasleen K Randhawa, MD, Mathew Thomas, Ayman A Saad, MD, Jeanne Palmer, MD, Parameswaran Hari, MBBS, MD, MRCP

Blood (2011) 118 (21): 1880.

https://doi.org/10.1182/blood.V118.21.1880.1880

Published: 2011

NARROW

Early Mortality in Patients with Acute Promyelocytic Leukemia (APL) Treated in Teaching Versus Non-Teaching Hospitals

Use of "Big Data" to Define Disease Burden, Complication Rates and Healthcare Costs in Patients with Heparin Induced Thrombocytopenia (HIT)

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Impact of Obesity on Outcomes of Elderly Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies

"Tailoring" Hematopoietic Progenitor Cell Collection: Impact of a Data-Driven Prediction Algorithm for Blood Volume Processing in Large Volume Leukapheresis

Phase 2 Study of Carfilzomib (CFZ) with or without Filanesib (FIL) in Patients with Advanced Multiple Myeloma (MM)

A Novel Tool Using Marrow Natural Killer (NK) Cell Percentages to Predict Collection Requirements of Peripheral Blood Mononuclear Cell (MNC), Apheresis Products Used in NK Cell Adoptive Immunotherapy

Phase 1B Results of Ricolinostat (ACY-1215) Combination Therapy with Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma (MM)

D-Dimer Kinetics, Chemotherapy and Risk of Bleeding in Acute Promyelocytic Leukemia

A Phase 1/2 Study of Weekly MLN9708, an Investigational Oral Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies After Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

Intermittent Zolendronic Acid (ZA) for the Prevention of Osteoporosis After Allogeneic Hematopoietic Cell Transplantation (HCT)

Lille Scoring System Rather Than DIPSS Is a Better Predictive of Overall Mortality After Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Myelofibrosis Using Reduced Intensity Conditioning: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Hematopoietic Cell Transplant Co-Morbidity Index (HCTCI) and Multiple Myeloma (MM) Survival After Autologous Hematopoietic Cell Transplantation (AHCT)

Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Trends in Utilization and Outcomes of Autologous Hematopoietic Cell Transplantation (AHCT) in the Upfront Management of Patients with Multiple Myeloma: A Cibmtr Analysis

Pre-Transplant Salvage Therapy Prior to Autologous Transplant (AHCT) in Patients Not Responding to Initial Induction for Multiple Myeloma (MM)

The Impact of Co-Morbidities on the Outcome of Autologous Stem Cell Transplantation for Multiple Myeloma

Biomarker Correlation with Outcomes in Patients with Relapsed or Refractory Multiple Myeloma on a Phase I Study of Everolimus in Combination with Lenalidomide,

Bortezomib Based Therapy for Newly Diagnosed Patients with Advanced Multisystem Light Chain Amyloidosis (AL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only